Natalie Yl Ngoi

15PUBLICATIONS
107CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 24, 2025
Clinical and biological characteristics associated with loss-of-heterozygosity in endometrial cancer.

Felix Blanc-Durand, Etienne Rouleau, Patricia Pautier

|Jul 24, 2025
Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial.

Natalie Y L Ngoi, Chel Hun Choi, Junxian Zhu

|Aug 14, 2024
Unveiling Commonalities: Exploring Shared Characteristics in Clear-Cell Carcinomas of the Gynecologic Tract.

Felix Blanc-Durand, Natalie Y L Ngoi, Diana G S Lim

|Feb 28, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.

Patrick G Pilié, Virginia Giuliani, Wei-Lien Wang

|Feb 20, 2024
Targeting ATR in patients with cancer.

Natalie Y L Ngoi, Patrick G Pilié, Daniel J McGrail

Pageof 3